approval
saveLAZCLUZE (LAZERTINIB MESYLATE) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalNov 7, 2025
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 6, 2025
- approvalustekinumab: STELARA (USTEKINUMAB) — FDA approvalNov 3, 2025
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 14, 2025
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 19, 2025
- approvalSIMPONI (GOLIMUMAB) — FDA approvalOct 22, 2025
comments(0)
5-min edit window · permanent after that